HC Wainwright & Co. Reiterates Buy on Immunocore Hldgs, Maintains $100 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating for Immunocore Holdings (NASDAQ:IMCR) and maintained a $100 price target.
June 05, 2024 | 3:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated a Buy rating for Immunocore Holdings and maintained a $100 price target, indicating strong confidence in the company's future performance.
The reiteration of a Buy rating and the maintenance of a $100 price target by a reputable analyst firm like HC Wainwright & Co. is likely to positively influence investor sentiment and could lead to a short-term increase in IMCR's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100